When MRI would be useful in patients without evidence of sacroiliitis on radiographs?
Rheumatology International · 2023
DOI: 10.1007/s00296-023-05468-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology International, 2023. Verfasst von Yeo-Jin Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Seoul, 05505, Republic of Korea. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Sacroiliitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Asan Institute for Life Sciences, Asan Medical Center.
Abstract (Originalsprache)
We aimed to identify when magnetic resonance imaging (MRI) would be useful to diagnose patients with suspected axial spondyloarthropathy (AxSpA) without evidence of sacroiliitis on radiographs. We retrospectively reviewed electronic medical records of patients who underwent pelvis MRI after radiographs at the rheumatology clinic in a single tertiary center in Korea. Patients underwent imaging from January 2020 to July 2022. We collected data including complete blood count, erythrocyte sedimentation rate, C-reactive protein (CRP), human leukocyte antigen (HLA)-B27, history of acute anterior uveitis (AAU), peripheral arthritis, dactylitis, inflammatory bowel disease (IBD), enthesopathy, and psoriasis. A total of 105 patients who showed no evidence of sacroiliitis on radiographs were included. The median age of patients was 41.0 years, and 44.8% were male. Of them, 34 showed sacroiliitis on MRI (group 1), and 71 showed no evidence of sacroiliitis even on MRI (group 2). Known AxSpA-related clinical features including AAU, peripheral arthritis, dactylitis, IBD, enthesopathy, and psoriasis were not different between the two groups. HLA-B27 positivity (79.4% vs. 40.0%, p < 0.001), median white blood cell count (7700 vs. 6300, p = 0.007), mean platelet count (307.7 ± 69.7 vs. 265.3 ± 68.9 × 103/µL, p = 0.005), and median CRP level (0.38 vs. 0.10, p = 0.001) showed significant differences between the two groups. In a multivariate analysis, HLA-B27 positivity and platelet count were significantly associated with sacroiliitis on MRI. In our cohort, sacroiliitis was observed on MRI in one-third of patients without radiographic evidence. MRI could be recommended to evaluate sacroiliitis in patients with positive HLA-B27 and a high platelet count.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Seoul, 05505, Republic of Korea.
- Department of Radiology, Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Information Medicine, Big Data Research Center, Asan Medical Center, Seoul, Republic of Korea.
- Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Seoul, 05505, Republic of Korea. bestmd2000@amc.seoul.kr.
ORCID-Profile: Yeo-Jin Lee, Sang Hoon Lee, Soo-Min Ahn, Seokchan Hong, Ji-Seon Oh, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim
Förderung
- Asan Institute for Life Sciences, Asan Medical Center
Zitieren
APA
Lee, Y. J., Lee, S. H., Ahn, S. M., Hong, S., Oh, J. S., Lee, C. K., Yoo, B., & Kim, Y. G. (2023). When MRI would be useful in patients without evidence of sacroiliitis on radiographs?. Rheumatology International. https://doi.org/10.1007/s00296-023-05468-2
Vancouver
Lee YJ, Lee SH, Ahn SM, Hong S, Oh JS, Lee CK, et al. When MRI would be useful in patients without evidence of sacroiliitis on radiographs?. Rheumatology International. 2023. doi:10.1007/s00296-023-05468-2
BibTeX
@article{Lee2023,
author = {Lee, Yeo-Jin and Lee, Sang Hoon and Ahn, Soo-Min and Hong, Seokchan and Oh, Ji-Seon and Lee, Chang-Keun and Yoo, Bin and Kim, Yong-Gil},
title = {When MRI would be useful in patients without evidence of sacroiliitis on radiographs?},
journal = {Rheumatology International},
year = {2023},
doi = {10.1007/s00296-023-05468-2}
}
EUVIMED